Dosimetric verification of point doses for I-125 implants designed by different manufacturers in prostate brachytherapy
The choice of implant manufacturer strongly influences what dose distribution will be obtained for the prostate. It is possible to obtain satisfactory plans that meet the dosimetric criteria for each type of implant, but the positioning of each source will vary significantly.
Authors
- Justyna Krupka
- Marek Kanikowski
- D. Borowicz
- Maciej Kozak (ORCID: https://orcid.org/0000-0003-3312-6518)
- Grzegorz Bielęda (ORCID: https://orcid.org/0000-0002-0191-546X)
- Aleksandra Lewandowska
- Oliwia Nowotka
- Maksymilian Kazior
Institutions
- Poznan University of Medical Sciences (PL)
- John Paul II Hospital (PL)
- Greater Poland Cancer Center (PL)
- Adam Mickiewicz University in Poznań (PL)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2024-12-04
- DOI
- https://doi.org/10.5603/rpor.102819
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00